BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Umehara Y, Kudo M, Kawasaki M. Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis. World J Gastroenterol 2008; 14(34): 5316-5321 [PMID: 18785285 DOI: 10.3748/wjg.14.5316]
URL: https://www.wjgnet.com/1007-9327/full/v14/i34/5316.htm
Number Citing Articles
1
Toshifumi Ashida, Yutaka Kohgo, Akihiro Munakata, Mitsunori Noguchi, Bunei Iizuka, Yutaka Endo, Hiroyuki Hanai, Toshikazu Yoshikawa, Takayuki Matsumoto, Nobuo Aoyama, Toshiyuki Matsui, Keiichi Mitsuyama, Toshifumi Hibi. A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitisTransfusion and Apheresis Science 2011; 44(2): 113 doi: 10.1016/j.transci.2011.01.001
2
Koji Nagayama, Hidetoshi Takedatsu, Keiichi Mitsuyama, Hiroshi Yamasaki, Kotaro Kuwaki, Shinichiro Yoshioka, Teppei Kobayashi, Ryosuke Yamauchi, Tatsuyuki Kakuma, Michio Sata. Univariate Analysis to Examine Predictors of Response to Leukocytapheresis in Ulcerative Colitis PatientsTherapeutic Apheresis and Dialysis 2014; 18(3): 244 doi: 10.1111/1744-9987.12211
3
Yoshihiro Endo, Motoki Yonekawa, Kazutaka Kukita, Masaki Katagiri, Takayuki Matsumoto, Keisuke Kawasaki, Shunichi Yanai, Shingo Kato, Kazuhito Kani, Tomonari Ogawa, Kazuya Kitamura, Izumi Hasegawa, Yusuke Inoue, Takuya Doi, Kazuhide Higuchi, Ken Kawakami, Kazuki Kakimoto, Hiroki Nakamura. Novel adsorptive type apheresis device Immunopure for ulcerative colitis from clinical perspectives based on clinical trials: Japan and EuropeTherapeutic Apheresis and Dialysis 2021; 25(4): 432 doi: 10.1111/1744-9987.13661